Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
1. Celcuity amended its credit facility, increasing total loans to $500 million. 2. New capital includes $100 million contingent on FDA approval for gedatolisib. 3. Funding supports FDA submission and launch preparations for gedatolisib. 4. Company's financial flexibility improved with extended interest-only period. 5. Phase 3 data showed positive results for gedatolisib in breast cancer.